These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2914301)

  • 1. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk.
    Dupont WD; Page DL; Rogers LW; Parl FF
    Cancer; 1989 Mar; 63(5):948-57. PubMed ID: 2914301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases.
    Thomas DB; Persing JP; Hutchinson WB
    J Natl Cancer Inst; 1982 Nov; 69(5):1017-25. PubMed ID: 6957648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of benign breast disease and the risk of breast cancer.
    London SJ; Connolly JL; Schnitt SJ; Colditz GA
    JAMA; 1992 Feb; 267(7):941-4. PubMed ID: 1734106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the development of breast cancer in 16,692 women with benign breast disease.
    Carter CL; Corle DK; Micozzi MS; Schatzkin A; Taylor PR
    Am J Epidemiol; 1988 Sep; 128(3):467-77. PubMed ID: 3414655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer.
    Dupont WD; Page DL
    Am J Epidemiol; 1987 May; 125(5):769-79. PubMed ID: 3565352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
    Dupont WD; Parl FF; Hartmann WH; Brinton LA; Winfield AC; Worrell JA; Schuyler PA; Plummer WD
    Cancer; 1993 Feb; 71(4):1258-65. PubMed ID: 8435803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for breast cancer in women with proliferative breast disease.
    Dupont WD; Page DL
    N Engl J Med; 1985 Jan; 312(3):146-51. PubMed ID: 3965932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy in women with a history of proliferative breast disease.
    Dupont WD; Page DL; Parl FF; Plummer WD; Schuyler PA; Kasami M; Jensen RA
    Cancer; 1999 Mar; 85(6):1277-83. PubMed ID: 10189132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal estrogen replacement therapy and breast cancer.
    Dupont WD; Page DL
    Arch Intern Med; 1991 Jan; 151(1):67-72. PubMed ID: 1824675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk in women with radial scars in benign breast biopsies.
    Berg JC; Visscher DW; Vierkant RA; Pankratz VS; Maloney SD; Lewis JT; Frost MH; Ghosh K; Degnim AC; Brandt KR; Vachon CM; Reynolds CA; Hartmann LC
    Breast Cancer Res Treat; 2008 Mar; 108(2):167-74. PubMed ID: 18297395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
    Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign breast disease and the risk of breast cancer.
    Hartmann LC; Sellers TA; Frost MH; Lingle WL; Degnim AC; Ghosh K; Vierkant RA; Maloney SD; Pankratz VS; Hillman DW; Suman VJ; Johnson J; Blake C; Tlsty T; Vachon CM; Melton LJ; Visscher DW
    N Engl J Med; 2005 Jul; 353(3):229-37. PubMed ID: 16034008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and incidence of benign breast disease.
    Byrne C; Webb PM; Jacobs TW; Peiro G; Schnitt SJ; Connolly JL; Willett WC; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1369-74. PubMed ID: 12433713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous estrogens and other factors in the epidemiology of breast cancer.
    Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
    J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of breast cancer, age and benign breast disease.
    Webb PM; Byrne C; Schnitt SJ; Connolly JL; Jacobs T; Peiro G; Willett W; Colditz GA
    Int J Cancer; 2002 Jul; 100(3):375-8. PubMed ID: 12115556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study.
    Tamimi RM; Byrne C; Baer HJ; Rosner B; Schnitt SJ; Connolly JL; Colditz GA
    Breast Cancer Res; 2005; 7(4):R555-62. PubMed ID: 15987462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.